Acesion Pharma is a clinical-stage biopharmaceutical company headquartered in Copenhagen, Denmark, specializing in the discovery and development of first-in-class therapies for atrial fibrillation (AF), the most common cardiac arrhythmia. Founded in 2011, the company leverages its deep understanding of cardiac ion channels to create safer and more effective treatments. Acesion's lead drug candidate, AP30663, is an SK channel inhibitor being developed for the acute conversion of AF in a hospital setting, aiming to address a significant unmet medical need.
The headquarters serve as the central hub for Acesion Pharma's research and development activities, clinical trial management, and corporate operations.
Located within COBIS (Copenhagen Bio Science Park), providing access to advanced laboratory facilities, shared services, and a vibrant biotech ecosystem conducive to innovation.
Acesion Pharma fosters a collaborative, research-intensive, and milestone-driven work environment. There is a strong emphasis on scientific excellence, innovation, and teamwork, leveraging the dynamic COBIS community.
The strategic location in COBIS, part of the Medicon Valley life science cluster, provides Acesion Pharma with access to top talent, research infrastructure, and a network of potential collaborators, crucial for its drug development programs.
While headquartered and primarily operating from Denmark, Acesion Pharma maintains a global outlook in its operations. This includes conducting international clinical trials for its drug candidates in multiple countries across Europe and potentially North America. The company also engages with a global network of scientific collaborators, partners, and investors, and aims for future commercialization of its products in key international markets.
Ole Maaløes Vej 3
Copenhagen N
Region Hovedstaden
Denmark
Address: Not Applicable
The company focuses on leveraging the rich life science ecosystem of the Copenhagen area and Medicon Valley for its operations and collaborations.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Acesion Pharma' leadership includes:
Acesion Pharma has been backed by several prominent investors over the years, including:
Acesion Pharma strengthened its executive leadership in the past year with the strategic appointment of a Chief Business Officer to drive its corporate and business development activities. No major executive departures were publicly announced during this period.
Discover the tools Acesion Pharma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Acesion Pharma likely uses a standardized corporate email format for its employees, typically combining parts of the employee's name with the company domain '@acesionpharma.com'. Common formats include first initial followed by last name.
[firstinitial][last]@acesionpharma.com
Format
jdoe@acesionpharma.com (example for Jane Doe)
Example
80%
Success rate
Acesion Pharma Press Release / Business Wire • November 28, 2023
Acesion Pharma announced the successful completion of a EUR 45 million Series B financing round. The round was co-led by new US investors NEA and New Leaf Venture Partners, with Alpha Wave Ventures also joining. Existing investors Novo Holdings, Wellcome, Industrifonden, and FC Capital participated....more
Acesion Pharma Press Release • October 2, 2023
Acesion Pharma announced the appointment of Peter L. Bogaert, MBA, as its new Chief Business Officer (CBO). Mr. Bogaert brings over 20 years of experience in the pharmaceutical and biotech industry....more
Acesion Pharma News • April 19, 2024
Acesion Pharma announced its participation and presentation of data at several key scientific conferences in the second quarter of 2024, including the European Heart Rhythm Association (EHRA) Congress and Heart Rhythm Society (HRS) meeting....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Acesion Pharma, are just a search away.